Article Information
History
- July 5, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eunseon Gwak1,*,
- Seung-Ah Choe1,2,*,
- Erdenetuya Bolormaa1,
- Young June Choe1,§,
- Chengbin Wang3,
- Jonathan Fix3,
- Muruga Vadivale3 and
- Matthew D. Rousculp3,§
- 1Korea University College of Medicine, Seoul, Korea
- 2Research and management center for health risk of particulate matter, Korea University, Seoul, Korea
- 3Novavax, Inc., Gaithersburg, MD, USA
- ↵§Correspondence:
Young June Choe, MD, PhD. Department of Pediatrics, Korea University College of Medicine, 73 Goryeodae-ro, Seongbuk-gu, Seoul 02841, Korea. Tel: +82-2-920-5090; Email: choey{at}korea.ac.kr; Matthew D. Rousculp, PhD, Real World Evidence, Novavax, Inc., 21 Firstfield Rd, Gaithersburg, MD 20878. Email: mrousculp{at}novavax.com
↵* Equally contributed to the manuscript
Posted July 05, 2024.
Short-Term Relative Effectiveness of Homologous NVX-CoV2373 and BNT162b2 COVID-19 Vaccinations in South Korea
